Biography: Dr. Fang Wu received her PhD from Central South University in 2009 and is a medical oncologist and Professor at The Second Xiangya Hospital of Central South University. She is currently a Visiting Professor at Stanford University School of Medicine (2023–2025). Dr. Wu also serves as the Deputy Director of the Hunan Cancer Mega-Data Intelligent Application and Engineering Research Center and as the Director of the Changsha Thoracic Cancer Prevention and Treatment Technology Innovation Center.
Her research focuses on lung cancer, immunotherapy resistance, tumor microenvironment, psycho-oncology, and translational research aimed at developing novel strategies to improve cancer outcomes. Her recent studies have been published extensively in prestigious medical research journals such as Nature Medicine and Lancet Oncology. Dr. Wu has delivered several oral presentations at ASCO (2020、2022) and ESMO 2023 annual meetings.
Dr. Wu is a member of the IASLC Staging and Prognostic Factors Group for revising the 10th edition TNM classifications. She is also the chair of Association of Stanford Chinese Visiting Physicians (ASCVP). She has been honored as an Excellent Young Scholar of Hunan Province in China, recognized as a High-Level Talent by the Hunan Health Commission, and awarded as an Outstanding Model Expert in the 3rd “People’s Good Doctor-Golden Camellia Project”.